Case number 1:25-cv-00754
Bayer Pharma AG et al v. Hetero Labs Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 24, 2025 | 21 | SO ORDERED Granting Stipulation and Order Regarding Stay (D.I. 378 in 21-md-3017-RGA-LDH; D.I. 182 in 21-cv-314-RGA-LDH; D.I. 20 in 25-cv-754-RGA). Signed by Judge Richard G. Andrews on 10/24/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:25-cv-00754-RGA(nms) (Entered: 10/24/2025) (2) |
| Oct 23, 2025 | 20 | STIPULATION and [Proposed] Order Regarding Stay as to C.A. No. 25-754-RGA - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2025 (nms). (Entered: 10/23/2025) (2) |
| Sep 9, 2025 | 19 | NOTICE of Change of Address by Kenneth Laurence Dorsney (Dorsney, Kenneth) (Entered: 09/09/2025) (2) |
| Sep 5, 2025 | 17 | ANSWER to 2 Complaint, by Ascent Pharmaceuticals Inc., Camber Pharmaceuticals, Inc., Hetero Labs Limited.(Dorsney, Kenneth) (Entered: 09/05/2025) (15) |
| Sep 5, 2025 | 18 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Limited for Camber Pharmaceuticals, Inc. filed by Ascent Pharmaceuticals Inc., Camber Pharmaceuticals, Inc., Hetero Labs Limited. (Dorsney, Kenneth) (Entered: 09/05/2025) (2) |
| Sep 3, 2025 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh - filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/03/2025) (11) |
| Sep 3, 2025 | 15 | Pro Hac Vice Fee - Credit Card Payment received for Stephanie P. Koh. ( re 14 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh )( Payment of $ 50, receipt number ADEDC-4780515).(Fahnestock, Derek) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | N/A | SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 9/3/2025. (aas) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | 16 | NOTICE requesting Clerk to remove Gwen Hochman Stewart as co-counsel. Reason for request: no longer associated with the case. (Fahnestock, Derek) (Entered: 09/03/2025) (9) |
| Jul 15, 2025 | 11 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Ascent Pharmaceuticals Inc. waiver sent on 7/7/2025, answer due 9/5/2025. (Fahnestock, Derek) (Entered: 07/15/2025) (1) |
| Jul 15, 2025 | 12 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Camber Pharmaceuticals, Inc. waiver sent on 7/7/2025, answer due 9/5/2025. (Fahnestock, Derek) (Entered: 07/15/2025) (1) |
| Jul 15, 2025 | 13 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Hetero Labs Limited waiver sent on 7/7/2025, answer due 9/5/2025. (Fahnestock, Derek) (Entered: 07/15/2025) (1) |
| Jun 25, 2025 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:25-cv-00753-UNA, 1:25-cv-00754-UNA (alb) (Entered: 06/25/2025) (0) |
| Jun 24, 2025 | N/A | CORRECTING ENTRY: The Complaint (D.I. 2 ) has been unsealed per the Order at D.I. 10 . (nms) (Entered: 06/24/2025) (0) |
| Jun 20, 2025 | 9 | Summons Issued as to Ascent Pharmaceuticals Inc. on 6/20/2025; Camber Pharmaceuticals, Inc. on 6/20/2025; Hetero Labs Limited on 6/20/2025. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | Remark: Exit electronic copies to Duty Judge (RGA). (mpb) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | 10 | ORAL ORDER: The motion to file the complaint under seal (D.I. 1 ) is denied. The description of the settlement is too general to think that public disclosure of the complaint or any part of it will work a serious harm to plaintiffs. Ordered by Judge Richard G. Andrews on 6/20/2025. (aas) Modified on 6/20/2025 (nms). (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | CORRECTING ENTRY: The docket text for D.I. 10 has been corrected to reflect the filing is an Oral Order. (nms) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | Remark: The MDL Panel has been notified of this new case. (mpb) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | Remark: Case submitted for routine judicial assignment. (mpb) (Entered: 06/20/2025) (0) |
| Jun 18, 2025 | 1 | MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Text of Proposed Order)(mpb) (Entered: 06/20/2025) (0) |
| Jun 18, 2025 | 2 | COMPLAINT with Jury Demand against Ascent Pharmaceuticals Inc., Camber Pharmaceuticals, Inc., Hetero Labs Limited (Filing fee $ 405, receipt number ADEDC-4714562) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Civil Cover Sheet)(mpb) Modified on 6/24/2025 (nms). (Entered: 06/20/2025) (0) |
| Jun 18, 2025 | 3 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 06/20/2025) (3) |
| Jun 18, 2025 | 4 | DECLARATION of David Schramm in support of 1 MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mpb) (Entered: 06/20/2025) (2) |
| Jun 18, 2025 | 5 | EXHIBITS A-B to 2 Complaint - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mpb) (Entered: 06/20/2025) (30) |
| Jun 18, 2025 | 6 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (mpb) (Entered: 06/20/2025) (1) |
| Jun 18, 2025 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG. (mpb) (Entered: 06/20/2025) (1) |
| Jun 18, 2025 | 8 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (mpb) (Entered: 06/20/2025) (1) |
